Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis.
- DOI
- 10.1016/j.maturitas.2025.108740
- Published
- 2025 Dec
- Container
- Maturitas
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.maturitas.2025.108740,
title = {Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis.},
author = {Shapiro C M M and Neal-Perry G and Stute P and Thurston RC and Wolfman W and English M and Wu X and Ottery FD},
year = {2025},
journal = {Maturitas},
doi = {10.1016/j.maturitas.2025.108740},
url = {https://doi.org/10.1016/j.maturitas.2025.108740}
}RIS
TY - JOUR TI - Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis. AU - Shapiro C M M AU - Neal-Perry G AU - Stute P AU - Thurston RC AU - Wolfman W AU - English M AU - Wu X AU - Ottery FD PY - 2025 JO - Maturitas DO - 10.1016/j.maturitas.2025.108740 UR - https://doi.org/10.1016/j.maturitas.2025.108740 ER -
APA
M, S. C. M., G, N., P, S., RC, T., W, W., M, E., X, W., & FD, O. (2025). Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis.. Maturitas. https://doi.org/10.1016/j.maturitas.2025.108740
Source records
- pubmed · retrieved 2026-09-27T12:24:13.600Z
- europe-pmc · retrieved 2026-09-27T12:24:13.619Z